banner
Sirtuins inhibitor Sirt2-IN-1, Purity ≥98%
Inquiry

Cat. No.: X24-05-ZQ353

Sirtuins inhibitor Sirt2-IN-1, Purity ≥98%

Synonym: 1862238-00-3; Sirt2-IN-1; N-(5-{3-[(1-Benzyl-1H-1,2,3-Triazol-4-Yl)methoxy]benzyl}-1,3-Thiazol-2-Yl)-2-[(4,6-Dimethylpyrimidin-2-Yl)sulfanyl]acetamide; CHEMBL4228286; N-[5-[[3-[(1-benzyltriazol-4-yl)methoxy]phenyl]methyl]-1,3-thiazol-2-yl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide; Sirtuins inhibitor

  • CAS Number: 1862238-00-3
  • Compound CID: 112499922
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Sirt2-IN-1 is a compound that blocks the activity of sirtuins, a family of NAD+-dependent deacetylases involved in the regulation of aging, metabolism, and stress resistance. It targets SIRT2.
Molecular Weight
557.69
Molecular Formula
C28H27N7O2S2
Targets
SIRT2: 163 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Sirt2-IN-1 aids in studying the impact of SIRT2 inhibition on cellular functions, including neurodegeneration.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0